Recent advances in treatment of wet age-related macular degeneration

• Main Authors: Ming Li, Wei Wei
• Format: Article
• Language: English
• Published: Press of International Journal of Ophthalmology (IJO PRESS) 2015-02-01
• Series: Guoji Yanke Zazhi
• Subjects: wet age-related macular degeneration; anti-vascular endothelial growth factor therapy; gene therapy
• Online Access: http://ies.ijo.cn/cn_publish/2015/2/201502016.pdf

Age-related macular degeneration(AMD)is one of the important eye diseases of the WHO present three big blindness, is one of the main blinding eye disease in people over the age of 50, people over the age of 65, about 2% of the disease caused by monocular blindness, as the population ages, AMD prevalence is increasing in our country. AMD with respect to its clinical manifestations can be divided into dry AMD and wet AMD, wet AMD is the most harmful for the vision of patients, at present there are many treatments for AMD(mainly for wet age-related macular degeneration), mainly including laser treatment, drug therapy, surgical treatment, gene therapy,<i>etc</i>. The treatments of AMD would be illuminated in this article.